series-c-plus
Stage
3
Investors
About
Alentis Therapeutics is a clinical-stage biotech company developing anti-Claudin-1 antibody-drug conjugates and monoclonal antibodies to treat cancer and reverse organ fibrosis.
Explore Alentis Therapeutics AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.